Business
Press Release Sep 20 2023
Venus Remedies Limited has informed the Exchange regarding a press release dated September 20, 2023, titled "Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel.".
About this update from Venus Remedies Limited
[{"type":"text","content":" Venus Remedies Limited has informed the Exchange regarding a press release dated September 20, 2023, titled \"Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel.\". View Attachment","length":396,"tagName":"div"}]